ArticlePloS one2011
Attitudinal and demographic predictors of measles-mumps-rubella vaccine (MMR) uptake during the UK catch-up campaign 2008-09: cross-sectional survey.
Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.
- Resurgence of Measles in Europe: A Systematic Review on Parental Attitudes and Beliefs of Measles Vaccine.Journal of epidemiology and global health · 2020Pooled it
- Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis.Human vaccines & immunotherapeutics · 2016Pooled it
- Assessing the psychometric properties of a modified vaccine hesitancy scale for measuring hepatitis B vaccine hesitancy among healthcare workers in Southern Ghana.BMC public health · 2025Article
- COVID-19 and regional inequalities in childhood vaccination uptake in England: a spline regression.BMC public health · 2025Article
- Article
- How does geographical diversity shape vaccine efficacy?Clinical and experimental vaccine research · 2024Review
- Faith and vaccination: a scoping review of the relationships between religious beliefs and vaccine hesitancy.BMC public health · 2024Article
- Article
- Mitigating Vaccine Hesitancy and Building Trust to Prevent Future Measles Outbreaks in England.Vaccines · 2023Article
- Attitude towards Intranasal Vaccines and Psychological Determinants: Effects on the General Population in Northern Italy.Vaccines · 2023Article
- Article
- Examining the effects of psychological reactance on COVID-19 vaccine acceptance: Comparison of two countries.Journal of global health · 2022Article
- Knowledge and Practice of Parents Towards Measles, Mumps and Rubella Vaccination.The Malaysian journal of medical sciences : MJMS · 2022Article
- The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal.BMC public health · 2022Article
- Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons.PloS one · 2022Article
- Review
- Perceptions and Attitudes of Parents Toward Vaccination of Children in Western Balkan Countries: Trust in the Function of Improving Public Health.Balkan medical journal · 2021Article
- The Impact of Online Media on Parents' Attitudes toward Vaccination of Children-Social Marketing and Public Health.International journal of environmental research and public health · 2020Article
- Epidemiologic profile of measles in Central African Republic: A nine year survey, 2007-2015.PloS one · 2019Article
- The impact of the media on the decision of parents in South Wales to accept measles-mumps-rubella (MMR) immunization.Epidemiology and infection · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveContinued suboptimal measles-mumps-rubella (MMR) vaccine uptake has re-established measles epidemic risk, prompting a UK catch-up campaign in 2008-09 for children who missed MMR doses at scheduled age. Predictors of vaccine uptake during catch-ups are poorly understood, however evidence from routine schedule uptake suggests demographics and attitudes may be central. This work explored this hypothesis using a robust evidence-based measure.
designCross-sectional self-administered questionnaire with objective behavioural outcome. SETTING AND
participants365 UK parents, whose children were aged 5-18 years and had received <2 MMR doses before the 2008-09 UK catch-up started.
main outcome measuresParents' attitudes and demographics, parent-reported receipt of invitation to receive catch-up MMR dose(s), and catch-up MMR uptake according to child's medical record (receipt of MMR doses during year 1 of the catch-up).
resultsPerceived social desirability/benefit of MMR uptake (OR = 1.76, 95% CI = 1.09-2.87) and younger child age (OR = 0.78, 95% CI = 0.68-0.89) were the only independent predictors of catch-up MMR uptake in the sample overall. Uptake predictors differed by whether the child had received 0 MMR doses or 1 MMR dose before the catch-up. Receipt of catch-up invitation predicted uptake only in the 0 dose group (OR = 3.45, 95% CI = 1.18-10.05), whilst perceived social desirability/benefit of MMR uptake predicted uptake only in the 1 dose group (OR = 9.61, 95% CI = 2.57-35.97). Attitudes and demographics explained only 28% of MMR uptake in the 0 dose group compared with 61% in the 1 dose group.
conclusionsCatch-up MMR invitations may effectively move children from 0 to 1 MMR doses (unimmunised to partially immunised), whilst attitudinal interventions highlighting social benefits of MMR may effectively move children from 1 to 2 MMR doses (partially to fully immunised). Older children may be best targeted through school-based programmes. A formal evaluation element should be incorporated into future catch-up campaigns to inform their continuing improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.